发明名称 Composition for therapeutic use, including an organic lipid phase and a rare-earth radioisotope complex
摘要 The invention relates to a therapeutic composition including a complex having the following formula (1), including a rare-earth radioisotope in ionic form, said complex being solubilized in an organic lipophilic phase: [M(L)3] in which: M denotes the rare-earth radioisotope in ionic form, and L denotes a tropolone ligand or a ligand derived from tropolone.
申请公布号 US9579409(B2) 申请公布日期 2017.02.28
申请号 US201314415282 申请日期 2013.07.17
申请人 CENTRE EUGENE MARQUIS;ECOLE NATIONALE SUPERIEURE DE CHIME;UNIVERSITE DE RENNES I 发明人 Lepareur Nicolas;Garin Etienne;Noiret Nicolas;Ardisson Valerie
分类号 A61P35/00;A61K103/32;A61K103/30;A61K51/04;A61K51/12 主分类号 A61P35/00
代理机构 Thomas | Horstemeyer, LLP 代理人 Thomas | Horstemeyer, LLP
主权项 1. A therapeutical composition, comprising a complex having the following formula (1) comprising a rare-earth radioisotope, said complex being solubilized in a lipophilic organic phase: [M(L)3]  (1)wherein: M designates the rare-earth radioisotope, wherein the rare-earth radioisotope is 90Y or 47Sc, and L designates a tropolone ligand or a tropolone-derived ligand chosen from amongst halogenotropolone, α-methyltropolone, β-methyltropolone, γ-methyltropolone, α-isopropyltropolone, β-isopropyltropolone, γ-isopropyltropolone, nootkatin, stipitatic acid, puberulic acid, puberulonic acid, purpurogallin, or colchicine.
地址 Rennes FR